Ipswich Investment Management Co., Inc. Surface Oncology, Inc. Transaction History

Ipswich Investment Management Co., Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 11, 2022	SELL	$1.05 - $2.1 $2,152 - $4,305	-2,050 Reduced 17.01%	10,000 $10,000
Q2 2022 Jul 26, 2022	SELL	$1.42 - $3.15 $5,680 - $12,600	-4,000 Reduced 24.92%	12,050 $20,000
Q1 2022 Apr 12, 2022	SELL	$2.65 - $5.08 $7,950 - $15,240	-3,000 Reduced 15.75%	16,050 $47,000
Q4 2021 Jan 24, 2022	SELL	$4.73 - $7.9 $7,095 - $11,850	-1,500 Reduced 7.3%	19,050 $91,000
Q3 2021 Oct 07, 2021	SELL	$5.16 - $7.98 $59,082 - $91,371	-11,450 Reduced 35.78%	20,550 $156,000
Q2 2021 Aug 05, 2021	BUY	$6.45 - $9.09 $206,400 - $290,880	32,000 New	32,000 $239,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Ipswich Investment Management Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Ipswich Investment Management Co., Inc. with notifications on news.